New Delhi, April 1 Marksans Pharma Ltd announced on Wednesday that it has received final approval from the US health regulator for its generic version of Benzonatate capsules, indicated for the treatment of persistent cough, bronchitis, pneumonia, or other lung infections.The approval from the...
New Delhi, February 26 Alembic Pharmaceuticals announced on Thursday that it has received approval from the US health regulator to market a generic medication for seizures.The drug company has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug...